Cyclocord 500 Mg & 1G 500 mg, 1 g Powder for solution for injection/infusion
PDF Leaflet Revision Date: 09 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Active treatment of neoplastic diseases and progressive autoimmune diseases.
Dosage (summary)
Administered by experienced oncologists; max 50 mg/kg body mass; adjust based on patient response.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in first trimester; avoid breastfeeding during treatment.
Key Drug Interactions
- Aprepitant
- Busulfan
- Ciprofloxacin
- Azole-antimycotics
- Warfarin
Contraindications
- Hypersensitivity to cyclophosphamide
- Severe bone marrow suppression
- Cystitis
- Infections
Common side effects
- Myelosuppression
- Nausea
- Vomiting
- Alopecia
- Infections
Counselling Points
- Avoid pregnancy during treatment
- Use effective contraception
- Monitor for infections
- Stay hydrated
Serious warnings
- Anaphylactic reactions
- Myelosuppression
- Urotoxicity
- Cardiotoxicity
- Pulmonary toxicity
Important Disclaimer
The Cyclocord 500 Mg & 1G 500 mg, 1 g Powder for solution for injection/infusion professional information leaflet below is the property of Accord Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
